Search Results 1251-1260 of 19888 for Receptor

1. Cetuximab With or Without Tivantinib in Treating Patients With Head and Neck Cancer That Is Recurrent, Metastatic, or Cannot Be Removed By Surgery - Mayo Clinic

   Patients who have received cetuximab or another inhibitor of epidermal growth factor receptor (EGFR) in the curative intent treatment setting (e.g. with ...

2. APL-101 Study of Subjects With NSCLC With c-Met EXON 14 Skip Mutations and c-Met Dysregulation Advanced Solid Tumors (SPARTA) - Mayo Clinic

   amplification and wild-type epidermal growth factor receptor (EGFR) with no more than 3 lines of prior therapy (MET Naive), Cohort D: basket of tumor types ...

3. SYMPHONY: A Study of Macitentan in Pulmonary Arterial Hypertension to Validate the PAH-SYMPACT - Mayo Clinic

   Treatment with endothelin receptor antagonists (ERAs) within 3 months prior to Visit 2, or scheduled to receive any of these compounds, other than macitentan, ...

4. Breast Cancer: PROMISE Study - Center for Individualized Medicine - Mayo Clinic Research

   A Prospective Study to Evaluate the Role of Tumor Sequencing in Women Receiving Palbociclib for Advanced Hormone Receptor (HR)-Positive Breast Cancer ...

5. Urshila Durani, M.D., M.P.H. - Mayo Clinic Faculty Profiles

   Financial toxicity and quality of life in survivors and caregivers after chimeric antigen receptor T-cell (CAR-T) therapy. Dr. Durani aims to understand the ...

6. Breast Cancer Clinical Trials - Mayo Clinic Research

   ... receptor 2 (HER2) breast cancer after chemotherapy, surgery, and/or radiation therapy. Aspirin is a drug that reduces pain, fever, inflammation, and blood ...

7. Sikander Ailawadhi, M.D. - Mayo Clinic Faculty Profiles

   He conducts phase 1 through phase 3 clinical trials for new drugs, including cellular therapies such as chimeric antigen receptor (CAR)-T cell therapy.

8. Publications - Johnny Yi, M.D. - Mayo Clinic

   ... Receptor-Positive Breast Cancer: Bilateral Oophorectomy vs. Gonadotropin-Releasing Hormone Agonist Therapy. Cancers (Basel). 2025 Sep 5; 17 (17) Epub 2025 ...

9. (VIDEO) H5N1 bird flu infections continue to rise: What you need to know - Mayo Clinic News Network

   There are receptors that the virus binds to in the eyes, so wearing eye protection is also important," says Dr. Binnicker. How to protect yourself from bird ...

10. Trial to Assess Safety and Effectiveness of MOR202 in Anti-PLA2R + Membranous Nephropathy (aMN) - Mayo Clinic

    on supportive treatment with an Angiotensin Converting Enzyme Inhibitor or an Angiotensin II Receptor Blocker for at least 4 weeks prior to Screening, having ...